SCHEMBL1245762

SCHEMBL1245762

C/C=C\c1cc(OC)c(O)c(OC)c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABL1 P00519 1/20 0.66
▸ BCR P11274 1/20 0.66
▸ CYP3A4 P08684 2/20 0.63
▸ CYP2B6 P20813 2/20 0.63
▸ TYR P14679 1/20 0.63
▸ CYP1A2 P05177 1/20 0.63
▸ CYP2D6 P10635 1/20 0.63
▸ CYP2C9 P11712 1/20 0.63
▸ PTGS1 P23219 2/20 0.61
▸ PTGS2 P35354 2/20 0.61
▸ PKM P14618 1/20 0.61
▸ TUBB1 Q9H4B7 1/20 0.59
▸ MAPT P10636 2/20 0.59
▸ KMT2A Q03164 2/20 0.59
▸ GAA P10253 2/20 0.59
▸ CCR3 P51677 1/20 0.56
▸ KDM4E B2RXH2 2/20 0.53
▸ MEN1 O00255 1/20 0.53
▸ LMNA P02545 1/20 0.53
▸ POLB P06746 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3504047 1.00 ABL1 (0.66) ABL1BCRCYP3A4CYP2B6TYR
SCHEMBL424528 1.00 ABL1 (0.66) ABL1BCRCYP3A4CYP2B6TYR
SCHEMBL30491036 0.92 TYR (0.65) ABL1BCRCYP3A4CYP2B6TYR
SCHEMBL10602315 0.92 TYR (0.65) ABL1BCRCYP3A4CYP2B6TYR
SCHEMBL21852875 0.92 TYR (0.65) ABL1BCRCYP3A4CYP2B6TYR
SCHEMBL2119058 0.92 TYR (0.65) ABL1BCRCYP3A4CYP2B6TYR
SCHEMBL21841319 0.90 TYR (0.58) ABL1BCRCYP3A4CYP2B6TYR
SCHEMBL16372856 0.89 ABL1 (0.80) ABL1BCRCYP3A4CYP2B6CYP1A2
SCHEMBL17843663 0.89 ABL1 (0.80) ABL1BCRCYP3A4CYP2B6CYP1A2
SCHEMBL23829549 0.88 PTGS1 (0.57) ABL1BCRCYP3A4CYP2B6TYR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210070684-A1 PRODUCTION OF HIGHLY PURE META,META-COUPLED BIS(4-ALKYLPHENOL) DERIVATIVES AND USES THEREOF KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2021-03-11 — — US claimed
US-20200317593-A1 LIGNIN CONVERSION TO PHENOLIC MOLECULES USING TRANSITION METAL CATALYSTS SPERO RENEWABLES, LLC 2020-10-08 — — US claimed
EP-3717496-A1 LIGNIN CONVERSION TO PHENOLIC MOLECULES USING TRANSITION METAL CATALYSTS Spero Renewables, LLC (US) 2020-10-07 — — EP claimed
US-20160198747-A1 1H-PYRROLE-DICARBONYL-DERIVATIVES AND THEIR USE AS FLAVORING AGENTS IMAX DISCOVERY GMBH (DE) 2016-07-14 — — US claimed
EP-3041370-A1 1H-PYRROLE-2,4-DICARBONYL-DERIVATIVES AND THEIR USE AS FLAVORING AGENTS IMAX Discovery GmbH (DE) 2016-07-13 — — EP claimed
WO-2015014607-A1 IMIDAZO[1,2-A]PYRIDINE-YLMETHYL-DERIVATIVES AND THEIR USE AS FLAVORING AGENTS IMAX DISCOVERY GMBH (DE) 2015-02-05 — — WO claimed
WO-2015014609-A1 1H-PYRROLE-2,4-DICARBONYL-DERIVATIVES AND THEIR USE AS FLAVORING AGENTS IMAX DISCOVERY GMBH (DE) 2015-02-05 — — WO claimed
EP-2832233-A1 1H-pyrrole-2,4-dicarbonyl-derivatives and their use as flavoring agents IMAX Discovery GmbH (DE) 2015-02-04 — — EP claimed
EP-2832234-A1 Imidazo[1,2-a]pyridine-ylmethyl-derivatives and their use as flavoring agents IMAX Discovery GmbH (DE) 2015-02-04 — — EP claimed
US-8592621-B2 Precursor compounds of sweet taste receptor antagonists for the prevention or treatment of disease SYMRISE AG (DE) 2013-11-26 — — US claimed
WO-2013135511-A1 N-(2,4-DIMETHYLPENTAN-3-YL)-METHYLBENZAMIDES AND THEIR USE AS FLAVORING AGENTS IMAX DISCOVERY GMBH (DE) 2013-09-19 — — WO claimed
US-20110045069-A1 PRECURSOR COMPOUNDS OF SWEET TASTE RECEPTOR ANTAGONISTS FOR THE PREVENTION OR TREATMENT OF DISEASE SYMRISE GMBH CO. KG (DE) 2011-02-24 — — US claimed
US-20250113823-A1 Arthropod Control Compositions FIRMENICH SA (CH) 2025-04-10 — — US disclosed
US-20240327878-A1 PSEUDOMONAS PUTIDA STRAINS ENGINEERED FOR PRODUCTION OF MUCONIC ACID FROM P-METHOXYLATED BENZOIC ACIDS Alliance for Energy Innovation, LLC 2024-10-03 — — US disclosed
US-20240108040-A1 HIGH INTENSITY SWEETENERS FIRMENICH INCORPORATED (US) 2024-04-04 — — US disclosed
EP-4321547-A1 CROSSLINKABLE SYSTEMS Prefere Resins Holding GmbH (DE) 2024-02-14 — — EP disclosed
US-20050123757-A1 Process for the preparation of flavor or fragrance microcapsules FIRMENICH S.A. (CH) 2005-06-09 — — US disclosed
WO-2005044247-A1 PHARMACEUTICAL COMPOSITION CONTAINING GUAIACOL DERIVATIVES AND SYRINGOL DERIVATIVES EXTRACTED FROM NATURAL PLANT VINEGAR OAKY NATURAL CO., LTD (KR) 2005-05-19 — — WO disclosed
WO-2005018889-A1 WOOD TREATMENT MITCHITE PTY LTD ACTING FOR THE CA & KR JOHNSON FAMILY TRUST (AU) 2005-03-03 — — WO disclosed
US-20040032036-A1 Process for the preparation of flavor or fragrance microcapsules FIRMENICH SA (CH) 2004-02-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240108040-A1 HIGH INTENSITY SWEETENERS TAS2R40, TAS2R60, TAS1R1 ABL1 4716/4885BCR 4691/4885CYP3A4 4332/4885
US-20210070684-A1 PRODUCTION OF HIGHLY PURE META,META-COUPLED BIS(4-ALKYLPHENOL) DERIVATIVES AND USES THEREOF MMS19, PCBP1, PBRM1 ABL1 4716/4885BCR 2573/4885CYP3A4 48/4885
US-20250113823-A1 Arthropod Control Compositions AGO2, EXOSC9, C5 ABL1 796/4885BCR 3892/4885CYP3A4 3083/4885
US-20110045069-A1 PRECURSOR COMPOUNDS OF SWEET TASTE RECEPTOR ANTAGONISTS FOR THE PREVENTION OR TREATMENT OF DISEASE TAS1R2, TAS2R5, TAS2R1 ABL1 4416/4885BCR 4768/4885CYP3A4 4088/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback